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Photodynamic therapy is a promising treatment
modality for a variety of cutaneous neoplasms and
other skin disorders. Studies suggest an involvement
of multiple pathways during photodynamic-therapy-
mediated cell death. A complete knowledge of the
mechanisms involved in photodynamic therapy may
lead to an improvement in its therapeutic ef®cacy.
In vitro as well as in vivo studies have shown the
involvement of apoptosis during photodynamic-
therapy-mediated cell death. The pathways by which
photodynamic therapy causes this are not fully
understood. In this study, employing human epider-
moid carcinoma (A431) cells and silicon phthalo-
cyanine 4 photodynamic therapy, we show that the
cell surface death receptor Fas (also known as APO-1
or CD-95) pathway is an important contributor to
photodynamic-therapy-mediated apoptosis. Employ-
ing ¯ow cytometric analysis and confocal micro-
scopy we ®rst established that silicon phthalocyanine
4 photodynamic therapy results in a signi®cant induc-
tion of apoptosis in A431 cells. Immunoblot analysis
revealed a signi®cant time-dependent increase in the
protein expression of Fas at 5, 15, 30, and 60min post-
photodynamic therapy followed by a decrease at later
time-points (2 and 3 h post-photodynamic therapy). A
Fas enzyme-linked immunosorbent assay demon-
strated an increase in this protein in cell culture
medium starting at 1 h post-photodynamic therapy
and showing a time-dependent response up to 3 h
following therapy, suggesting a diffusion of soluble Fas
from cells into the medium from 1 h after photo-
dynamic therapy. Silicon phthalocyanine 4 photo-
dynamic therapy also resulted in a time-dependent
increase in (i) the multimerization of Fas protein,
(ii) the protein expression of Fas ligand, (iii) FADD, an
adapter molecule for Fas, and (iv) the binding of
FADD with Fas. Silicon phthalocyanine 4 photo-
dynamic therapy also caused a signi®cant activation of
FLICE, as evident from the appearance of cleaved pro-
ducts of pro-caspase 8. Further, a pretreatment of cells
with rhFas:Fc fusion protein or general caspase inhibi-
tor Z-VAD-FMK followed by silicon phthalocyanine 4
photodynamic therapy resulted in a signi®cantly
enhanced cell survival. Taken together, our data, for
the ®rst time, delineate an involvement of the Fas
pathway as an important contributor to photo-
dynamic-therapy-mediated apoptosis of cancer cells.
These observations may be important for improving
the ef®cacy of photodynamic therapy for the treat-
ment of skin cancer and possibly other skin disorders.
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Dermatol 115:1041±1046, 2000
P
hotodynamic therapy (PDT) is a relatively new therapeu-
tic procedure used for the management of a variety of solid
tumors including skin cancer and is showing promise for
the management of many nonmalignant diseases including
dermatologic disorders (Colussi et al, 1998; Dougherty
et al, 1998; Fritsch et al, 1998; Oleinick and Evans, 1998; Kalka et al,
2000). The United States Food and Drug Administration has
approved the use of photodynamic therapy for endobronchial and
esophageal tumors (Dougherty et al, 1998;Oleinick andEvans, 1998).
More recently, PDT has also been approved for treating actinic
keratoses. The approval of PDT for management of skin cancers and
metastatic cutaneous and subcutaneous breast cancers is expected,
based on investigator-initiated and other clinical trials. Investigator-
initiated clinical trials for psoriasis, alopecia areata, atherosclerosis,
vascular restenosis, age-related macular degeneration, rheumatoid
arthritis, and wound healing are currently ongoing (Colussi et al,
1998; Dougherty et al, 1998; Fritsch et al, 1998; Oleinick and Evans,
1998; Kalka et al, 2000). PDT relies on a bimodal protocol with two
components: (i) chemical photosensitization, and (ii) light irradiation.
Both of these components, individually, are nontoxic but they are
tumoricidal in combination (Colussi et al, 1998; Dougherty et al,
1998; Fritsch et al, 1998; Oleinick and Evans, 1998). PDT involves a
selective uptake of a porphyrin-based photosensitizing chemical in
the tumor relative to the surrounding normal tissue followed by light
irradiation in the visible ornear infrared region that is typically derived
through a laser. This causes a photoactivation leading to oxidative
damage to a variety of cellular targets that subsequently results in the
death of cancerous cells and thereby ablation of the tumor. The
molecular mechanism(s) of PDT-mediated cell killing and the
subsequent tumor ablation is not well understood. PDT-mediated
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oxidative stress has been shown to increase the expression of early
response genes (c-fos, c-jun, c-myc, egr-1), as well as glucose-regulated
protein and heme oxygenase (Luna et al, 1994; Oleinick and Evans,
1998). The involvement of heat shock protein HSP-70 (Gomer et al,
1996), nuclear factor kB (Ryter and Gomer, 1993), and the mitogen-
activated protein kinase (MAPK) pathway (Tao et al, 1996; Klotz et al,
1998; Assefa et al, 1999) has also been documented in PDT response.
PDT is known to exert oxidative stress and induce apoptosis both in
vitro and in vivo (Colussi et al, 1998; Dougherty et al, 1998; Fritsch et al,
1998; Oleinick and Evans, 1998). The involvement of apoptosis has
been shown to be an early response of PDT, both in vitro and in vivo
(Agarwal et al, 1993, 1996;Zaidi et al, 1993;Ahmad et al, 1998;Colussi
et al, 1998; Colussi et al, 1999). Based on many studies from this
laboratory and elsewhere, it is becoming clear that multiple pathways
are involved during PDT-mediated cell death. Therefore, a
hypothesis is put forward that a synergistic activation of apoptosis-
inducing pathways via a combination therapy may enhance the
therapeutic ef®cacy of PDT. This warrants concerted detailed efforts
to decipher the mechanism(s) involved in PDT-mediated apoptosis.
In this study, we have attempted to investigate our hypothesis
that the cell surface death receptor Fas pathway is an important
contributor to PDT-mediated apoptosis. The rationale for this
hypothesis is based on three major observations. First, it is
becoming clear that multiple pathways are involved during
PDT-mediated apoptosis. This is based on our recent studies
showing that silicon phthalocyanine 4 (Pc4)-PDT-mediated cell
cycle deregulation and/or apoptosis involves (i) an increased
production of nitric oxide (Gupta et al, 1998), (ii) a WAF1/
p21-mediated inhibition of the cyclin-cyclin dependent kinase
network (Ahmad et al, 1998), and (iii) a deregulation of pRb/
E2F-DP machinery (Ahmad et al, 1999). Several other
laboratories have shown the involvement of bcl2/bax/bcl-x(l)
(He et al, 1996; Granville et al, 1998; Kim et al, 1999),
phospholipases A2 and C (Agarwal et al, 1993), intracellular
Ca2+ (Agarwal et al, 1993; Tajiri et al, 1998), ceramide
(Separovic et al, 1997; 1998), caspases (Granville et al, 1998;
Varnes et al, 1999), c-Jun N-terminal kinase (JNK)/p38 MAPK
(Klotz et al, 1998; Assefa et al, 1999), and cytochrome C release
(Granville et al, 1998; Varnes et al, 1999) during PDT-mediated
apoptotic cell death. Thus, it is becoming clear that multiple
pathways are involved during Pc4-PDT-mediated cell death.
The involvement of multiple pathways is also evident from our
earlier study where we showed that PDT results in G0-G1-
phase arrest of A431 cells mediated by WAF1/p21 cyclins (E
and D1)±cyclin dependent kinases (2 and 6) that ultimately leads
to their apoptotic death (Ahmad et al, 1998). In this study, we
observed that at 12 h following PDT only 69% cells were
arrested in the G0-G1 phase whereas 89% cells were found to
be apoptotic at this time. This observation indicated that in
addition to the cell-cycle-mediated apoptosis, other mechan-
ism(s) of apoptosis may also be operative. Second, the Fas
pathway is intimately associated with sphingomyeline/ceramide,
caspase activation and JNK/p38 MAPK regulation (Brenner et al,
1997; 1998; Juo et al, 1998). Finally, PDT is known to exert
oxidative stress and Fas has been shown to be a redox
responsive signaling molecule (Peter and Krammer, 1998;
Schulze-Osthoff et al, 1998).
In this study, we demonstrate the involvement of the Fas
pathway during Pc4-PDT-mediated apoptosis.
MATERIALS AND METHODS
Cells The human epidermoid carcinoma (A431) cells were maintained in
Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10%
fetal bovine serum and 1% penicillin/streptomycin. The cells were
maintained in an atmosphere of 95% air/5% CO2 in a 37°C humidi®ed
incubator under standard conditions.
Photodynamic therapy The photosensitizer Pc4, synthesized as
described earlier (Oleinick et al, 1993), was kindly provided by Dr.
Malcolm E. Kenney of the Department of Chemistry. The cells (80%
con¯uent) were incubated overnight with Pc4 (0.5 mM in
dimethylsulfoxide) in DMEM in a 100 3 20 mm style Falcon disposable
cell culture dish. Cells were then washed with Hank's balanced salt solution
(HBSS) (with Ca2+ and Mg2+) and irradiated (in HBSS with Ca2+ and
Mg2+) with 15 kJ per m2 of light, as measured with a digital photometer
(Tektronix, Beaverton, OR), using a 300 W halogen lamp. The light
delivered was ®ltered through a Lee primary red ®lter #106 (Vincent
Lighting, Cleveland, OH) to remove light with wavelength less
than 600 nm. After irradiation, the cells were washed with phosphate-
buffered saline (PBS) and incubated, in DMEM, in the dark for selected
times in a humidi®ed incubator at 37°C. Appropriate controls, as speci®ed
at appropriate places, were also included. After the speci®ed times, the
medium was aspirated and the cells were washed with cold PBS (10 mM,
pH 7.4) and processed as desired.
Detection of apoptosis by ¯ow cytometry The cells were treated
with Pc4 and light as described above and harvested at 1, 3, 6, and 12 h
following PDT. The cells were trypsinized and collected in a 50 ml Falcon
tube. In this experiment, the ¯oating cells were also collected and included
in the assay. The cells were washed with PBS twice and the extent of
apoptosis was quanti®ed by using APO-DIRECTtm ¯ow cytometry kit
(Phoenix Flow System, San Diego, CA) as per the manufacturer's protocol.
Figure 1. Induction of apoptosis by Pc4-PDT. (A) Flow cytometric analysis. The A431 cells were subjected to Pc4-PDT, labeled with deoxyuridine
triphosphate using terminal deoxynucleotide transferase and propidium iodide, and analyzed by ¯ow cytometry as described in Materials and Methods. The
data are displayed as percentage apoptotic cells and represent the mean 6 SEM from three experiments. (B) Confocal microscopy analysis. The A431 cells
were subjected to Pc4-PDT and analyzed for morphologic changes as described in Materials and Methods. Panel A represents normal nonapoptotic cells; panel
B shows an early apoptotic cell (data shown here represent a picture of a cell taken 1 h post-PDT); panel C shows a late apoptotic cell (data shown here
represent a picture of a cell taken 12 h post-PDT). The data shown here are from a representative experiment repeated twice with similar results.
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Detection of apoptosis by confocal microscopy The cells were
cultured on round glass coverslips in a 60 mm culture dish to about 70%
con¯uency and subjected to Pc4-PDT for selected times as described
above. The cells were then labeled with 10 mM SYTO 13 (Molecular
Probes, Eugene, OR) by incubating with the dye for 20 min in complete
medium at 37°C. The coverslips were washed with PBS and mounted. The
SYTO 13 ¯uorescence was excited by an argon-krypton laser with 488 nm
wavelength and imaged through a 460 nm dichroic re¯ector and 514±
540 nm emission ®lter with a Zeiss 410 laser scanning confocal microscope.
Apoptosis was characterized by morphologic changes, namely chromatin
condensation, nuclear condensation, and formation of apoptotic bodies.
Preparation of cell lysates and immunoblot analysis The cells were
treated with Pc4 and light as described above and incubated for the
speci®ed time. The cells were then washed with cold PBS (10 mM, pH
7.4); ice-cold lysis buffer (50 mM Tris-HCl, 150 nM NaCl, 1 mM
ethyleneglycol-bis(b-aminoethyl ether)-N,N,N¢,N¢-tetraacetic acid, 1 mM
ethylenediamine tetraacetic acid, 20 mM NaF, 100 mM Na3VO4, 0.5%
Nonidet P-40, 1% Triton X-100, 1 mM phenylmethylsulfonyl ¯uoride,
10 mg per ml aprotinin, 10 mg per ml leupeptin; pH 7.4) was added and the
cells were left over ice for 30 min. The cells were scraped, and the lysate
was collected in a microfuge tube and passed through a 211/2 G needle to
break up the cell aggregates. The lysate was cleared by centrifugation at
Figure 3. Multimerization of Fas by Pc4-PDT in A431 cells. (A) Immunoblot analysis. The cells were subjected to Pc4-PDT and harvested at 5, 15,
30, and 60 min following the light treatment. Total cell lysates were prepared and Fas protein (50 mg) was immunoprecipitated using anti-Fas antibody (Apo-
1, Kamiya Biomedical Company) at 0.5 mg per ml (limiting antibody) or 10 mg per ml (excess antibody). The immunocomplex was subjected to SDS-PAGE
followed by immunoblot analysis using anti-Fas antibody. The proteins were detected by chemiluminescence. Equal loading was con®rmed by stripping the
membrane and re-probing it with b-actin (data not shown). The details are described in Materials and Methods. Data from a typical experiment repeated twice
with similar results are shown. (B) Quanti®cation of the protein bands. The protein bands were quanti®ed using Scion Image Software. The density of the
band corresponding to the untreated control was taken as unity. The data represent relative density normalized to b-actin and are expressed as mean 6 SEM
of three experiments.
Figure 2. Effect of Pc4-PDT on protein expression of Fas in A431 cells. (A) Immunoblot analysis. The cells were subjected to PDT and
harvested at 5, 15, 30, 60, 120, and 180 min following the light treatment. Total cell lysates were prepared and 50 mg protein was subjected to SDS-
PAGE followed by immunoblot analysis using anti-Fas antibody. The proteins were detected by chemiluminescence. The details are described in
Materials and Methods. Equal loading was con®rmed by stripping the membrane and re-probing it with b-actin (data not shown). The data shown
here are from a representative experiment repeated three times with similar results. (B) Quanti®cation of the protein bands. The protein bands were
quanti®ed using Scion Image Software. The density of the band corresponding to the untreated control was taken as unity. The data represent
relative density normalized to b-actin and are expressed as mean 6 SEM of three experiments. (C) Effect of Pc4-PDT on Fas protein in culture
medium by ELISA. Following PDT the cells were harvested at speci®ed times and the amount of Fas protein in the culture medium was detected
by Fas/APO-1 ELISA kit obtained from Oncogene Research Products according to the manufacturer's protocol. The details are described in
Materials and Methods. The data represent the mean 6 SEM from three experiments.
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14,000 3 g for 15 min at 4°C and the supernatant (total cell lysate) was
either used immediately or stored at ±70°C. The protein concentration was
determined by DC Bio-Rad assay using the manufacturer's protocol (Bio-
Rad Laboratories, Hercules, CA).
For immunoblot analysis, 25±50 mg protein was resolved over 12%
polyacrylamide sodium dodecyl sulfate gels and transferred onto a
nitrocellulose membrane. The membrane was incubated in blocking buffer
(5% nonfat dry milk, 1% Tween 20, in Tris-buffered saline, pH 7.6) for 1 h
at room temperature and incubated with appropriate human reactive
primary antibody (anti-Fas from Santa Cruz Biotechnology, Santa Cruz,
CA; anti-FasL and anti-FADD from Transduction Laboratories, Lexington,
KY; anti-FLICE from Upstate Biotechnology, Lake Placid, NY) in
blocking buffer for 1 h to overnight at 4°C. The membrane was then
incubated with antimouse or antirabbit secondary antibody horseradish
peroxidase conjugate (Amersham Life Sciences, Arlington Heights, IL)
followed by detection using an enhanced chemiluminescence kit
(Amersham Life Sciences).
The density of the bands was quanti®ed using Scion Image Software
(Scion Corporation, Frederck, MD), which is based on NIH Image for
Macintosh and modi®ed for Windows by Scion Corporation.
Immunoprecipitation For immunoprecipitation, the cell lysates
containing about 50 mg of protein (in a total volume of 1.0 ml) were
precleared by incubating with 1 mg of normal mouse IgG and 20 ml of
Protein-A-Sepharose 4B fast ¯ow (Pharmacia Biotech, Piscataway, NJ) for
1 h at 4°C. The supernatant was collected and incubated with 1.0 mg of
anti-Fas antibody (Apo-1, Kamiya Biomedical Company, Seattle, WA) for
2 h. Then, 20 ml of Protein-A-Sepharose was added and it was incubated
overnight at 4°C. The beads were collected by centrifugation at 2500 rpm
at 4°C and washed with RIPA buffer three times following the
centrifugation steps. The immunocomplexes were resolved over a 12%
polyacrylamide sodium dodecyl sulfate gel, followed by immunoblot
analysis and chemiluminescent detection as described above.
Fas enzyme-linked immunosorbent assay (ELISA) To assess the
effect of Pc4-PDT on the levels of soluble Fas protein, we performed Fas/
APO-1 quantitative ELISA using a kit obtained from Oncogene Research
Products (Cambridge, MA). The cells were incubated overnight with Pc4
and then irradiated with light as described above. The cells were then
incubated in the dark for 5, 15, 30, 60, 120, and 180 min following light
treatment in a humidi®ed incubator at 37°C. The medium was collected
and Fas protein was analyzed by ELISA performed according to the
manufacturer's protocol.
Treatment of cells with Fas:Fc fusion protein and Z-VAD-
FMK To assess the effect of blockade of the Fas pathway on Pc4-
PDT-mediated cell survival, we employed Fas:Fc fusion protein kit (Alexis,
San Diego, CA) as per the manufacturer's protocol. Brie¯y, A431 cells
(50,000 cells in 100 ml complete DMEM) were incubated simultaneously
with 100 mg per ml of rhFas:Fc fusion protein and 1 mg per ml enhancer
protein (for 24 h) and Pc4 (0.5 mM, overnight) in a 96 well plate at 37°C,
and this was followed by light treatment as described above. The cells were
washed with PBS and incubated in the dark (in DMEM) for 6 or 12 h. The
viability of cells was measured by 3-(4,5-dimethylthiazol)-2-yl (MTT)-
based colorimetric assay employing a kit obtained from Roche Molecular
Biochemicals (Indianapolis, IN) exactly as the manufacturer's protocol.
To assess the effect of general caspase inhibitor Z-VAD-FMK on Pc4-
PDT-mediated cell survival, we treated the A431 cells (50,000 cells in
100 ml complete DMEM) simultaneously with 100 mM Z-VAD-FMK (for
24 h) and Pc4 (0.5 mM, overnight) in a 96 well plate at 37°C, followed by
light treatment as described above. The cells were washed with PBS and
incubated in the dark (in DMEM) for 6 or 12 h. The viability of the cells
was measured by MTT assay as described above.
RESULTS AND DISCUSSION
This study was designed to de®ne the involvement of the cell
surface death receptor Fas pathway as an important contributor of
Figure 4. Effect of Pc4-PDT on the protein expression of FasL, FADD, and binding of FADD with Fas in A431 cells. (A) Immunoblot analysis.
For the effect of Pc4-PDT on FasL and FADD, the cells were harvested at designated times following PDT, total cell lysates were prepared, and 50 mg
protein was subjected to SDS-PAGE followed by immunoblot analysis using appropriate primary antibodies and secondary horseradish peroxidase
conjugates. The proteins were detected by chemiluminescence. Equal loading was con®rmed by stripping the membrane and re-probing it with b-actin
(data not shown). For the effect of Pc4-PDT on the binding of FADD with Fas, the Fas protein (50 mg) was immunoprecipitated using excess of anti-Fas
antibody (Apo-1, Kamiya Biomedical Company). The immunocomplex was subjected to SDS-PAGE followed by immunoblot analysis using anti-FADD
antibody. The proteins were detected by chemiluminescence. Equal loading was con®rmed by stripping the membrane and re-probing it with b-actin (data
not shown). The details are described in Materials and Methods. Data from a typical experiment repeated three times with similar results are shown. (B)
Quanti®cation of the protein bands. The protein bands were quanti®ed using Scion Image Software. The density of the band corresponding to the untreated
control was taken as unity. The data represent relative density normalized to b-actin and are expressed as mean 6 SEM of three experiments.
Figure 5. Effect of Pc4-PDT on FLICE in A431 cells. The cells were
subjected to PDT and harvested at 1, 5, 15, 30, and 60 min following the
light treatment. Total cell lysates were prepared and 50 mg protein was
subjected to SDS-PAGE followed by immunoblot analysis using anti-
FLICE antibody. The proteins were detected by chemiluminescence. Equal
loading was con®rmed by stripping the membrane and re-probing it with
b-actin (data not shown). The details are described in Materials and Methods.
The data shown here are from a representative experiment repeated three
times with similar results.
1044 AHMAD ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
PDT-mediated apoptosis. In our experiments, we employed (i)
A431 cells, a keratinocyte-derived cell line, as the model cell line,
and (ii) silicon phthalocyanine, termed ``Pc4'', as the model
photosensitizer. Employing ¯ow cytometric analysis of the cells
labeled with F-dUTP and propidium iodide, we ®rst established
that Pc4-PDT causes apoptosis of A431 cells. As shown by data in
Fig 1(A), PDT was found to result in a signi®cant induction of
apoptosis in A431 cells at 3, 6, and 12 h post-PDT (Fig 1A). The
induction of apoptosis by Pc4-PDT was also evaluated by confocal
microscopy after labeling the cells with SYTO 13, as this method
can identify the early apoptotic cells. As shown by the data in
Fig 1(B), early apoptotic morphology was evident even at 1 h
following PDT. As the Fas pathway is known to be activated much
before the fragmentation of DNA, we chose 5, 15, 30, 45, 60, 120,
and 180 min time-lag following PDT (unless otherwise stated) for
the rest of the study.
As Fas and Fas ligand (FasL) are the complementary receptor-ligand
proteins eliciting apoptosis via caspase activation, and studies have
shown that PDT results in activation of caspases (Granville et al, 1998;
Varnes et al, 1999), employing immunoblot analysis, we studied the
effect of Pc4-PDT on the protein expression of Fas in A431. As shown
by thedata inFig 2(A,B), a signi®cant time-dependent increase in the
protein expression of Fas was observed at 5, 15, 30, and 60 min post-
PDT in A431 cells. In immunoblot analysis Fas protein was observed
as a doublet, a strong upper band and a lower band. This is consistent
with earlier reports and may be due to the insoluble and soluble forms
of Fas proteins, respectively (Catlett and Bishop, 1999). The observed
rapid increase in the Fas protein is an interesting observation, as 5 min
does not appear to be a suf®cient time for de novo protein synthesis.
The reason for this rapid increase is not clear at present. It appears that
it may be due, however, to extremely fast protein synthesis that might
have started during the treatment of cells with light, because the time
to deliver 15 kJ per m2 light was about 7.5 min in our experimental
setup, which, in fact, increases the time-lag for 5 min post-PDT
samples to 12.5 min. Another interesting observation of this
experiment was that at 2 h and 3 h post-PDT the level of Fas protein
was found to decrease. This decrease in Fas is probably due to the
diffusion of this soluble protein from the cells into the cell culture
medium. To further investigate this possibility, we performed ELISA
using Fas quantitative assay kit (Oncogene Research Products). We
evaluated the effect ofPc4-PDTon the levels of Fas protein released in
the culture medium. As shown by the data in Fig 2(C), we found an
increase in Fas protein in cell culture medium starting at 1 h post-PDT
and showing a time-dependent response up to 3 h following PDT.
These data further support our assumption of diffusion of the soluble
Fas protein from cells into the medium after 1 h following PDT.
Studies have shown that, upon activation, Fas is trimerized to
transduce the death signal to FADD/MORT1 (Fas associated
through death domain) via a dynamic interaction with it through its
death domain, which itself can induce cell death upon over-
production (Chinnaiyan et al, 1995; Fraser and Evan, 1996; Peter
et al, 1998; Schulze-Osthoff et al, 1998). Therefore, in order to detect
Fas multimerization following Pc4-PDT, we immunoprecipitated
Fas employing a protocol described by Rehemtulla et al (1997). When
a limited anti-Fas antibody concentration is used to immunopreci-
pitate, more Fas molecules will be immunoprecipitated following
PDT-mediated aggregation of Fas. In contrast, when an excess of
antibody is used, the immunoprecipitated Fas antigen will be constant
irrespective of PDT. As shown by the data in Fig 3, at limiting
antibody concentration, a PDT time-dependent increase in Fas was
observed, whereas with excess antibody no change in the amount of
Fas protein was observed. This suggested that Pc4-PDT results in a
multimerization of Fas, for its activation.
Employing immunoblot analysis, we next evaluated the effect of
Pc4-PDT on the protein expression of FasL. As shown by the data
in Fig 4, Pc4-PDT was found to result in a signi®cant time-
dependent increase in FasL and followed a similar pattern to that
shown by Fas. We also investigated the effect of Pc4-PDT on (i)
FADD, and (ii) the binding of FADD to Fas. Our data (Fig 4)
demonstrate that Pc4-PDT of A431 cells results in a time-
dependent increase, for up to 1 h post-PDT, in FADD protein
levels. To investigate the effect of Pc4-PDT on the binding of
FADD with Fas, we immunoprecipitated Fas-FADD complex
using an antibody directed against Fas, followed by gel electro-
phoresis and immunoblot analysis using an antibody directed
against FADD. As shown by the data in Fig 4, Pc4-PDT results in a
time-dependent increase in the binding of FADD with Fas. As
FADD is known to recruit an interleukin-1b-converting enzyme
(ICE)-like protease known as FLICE (FADD-like-ICE, also
known as MACH-5 or caspase 8) to initiate cystein-like protease
cascade (Muzio et al, 1996), we also assessed the effect of Pc4-PDT
on FLICE activation. Our data (Fig 5) show that Pc4-PDT causes
an activation of FLICE in A431 cells, which is evident from the
appearance of cleaved products of pro-caspase 8. Previous studies
have shown the involvement of caspase 8 and cytochrome C during
PDT-mediated cell death (Granville et al, 1998). Another recent
study has also shown a caspase-8 mediated caspase 3 activation and
cytochrome C release during singlet-oxygen-induced apoptosis
(Zhuang et al, 1999). As the generation of singlet oxygen and other
reactive oxygen intermediates is believed to be a prerequisite for
the PDT effect, it is possible that the Fas-FADD-mediated
activation of caspase 8 shown here is preceded by caspase 3
activation and subsequent release of cytochrome C from mito-
chondria resulting in an apoptotic death of A431 cells.
Figure 6. Effect of pretreatment of cells with Fas:Fc fusion protein
and caspase inhibitor Z-VAD-FMK on Pc4-PDT-mediated cell
survival in A431 cells. Cells were incubated simultaneously with 100 mg
per ml of rhFas:Fc fusion protein and 1 mg per ml enhancer protein (for
24 h) or 100 mM Z-VAD-FMK and Pc4 (0.5 mM, overnight) in a 96 well
plate at 37°C, and subjected to light treatment. Six hours or 12 h following
light treatment, the viability of the cells was assessed by MTT assay. The
details are described in Materials and Methods. The data are the mean 6 SEM
from three experiments. Figure 7. Proposed scheme showing the involvement of the Fas
pathway as a mechanism of PDT-mediated apoptosis. Up arrows (­)
demonstrate an activation/upregulation of the speci®ed molecule.
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Finally, to further con®rm the involvement of the Fas pathway
during Pc4-PDT-mediated apoptosis, we employed an approach of
blocking FasL-mediated lysis of the cells using rhFas:Fc fusion
protein. As shown by the data in Fig 6(A), a pretreatment of cells
with Fas:Fc followed by Pc4-PDT resulted in a signi®cant increase
in cell viability compared with Pc4-PDT-treated cells. This
observation con®rms that the Fas pathway is, at least in parts,
involved during Pc4-PDT-mediated apoptosis. Further, a pretreat-
ment of cells with general caspase inhibitor Z-VAD-FMK followed
by Pc4-PDT also resulted in a signi®cant increase in cell survival
(Fig 6B) showing a de®nite involvement of caspases, which are
downstream effector molecules in the Fas pathway.
Taken together, as shown in Fig 7, the results presented here for
the ®rst time delineate that PDT-caused apoptosis may be mediated
via the Fas-FasL system, which triggers the downstream FADD-
FLICE death effector pathway. These observations are important
because recently it has been shown that Fas-FasL-mediated
apoptosis is important for skin homeostasis and that dysregulation
of the Fas-FasL system may be critical to the development of skin
cancer (Hill et al, 1999). Therefore, our study delineating the
involvement of the Fas-FasL system during PDT-mediated
apoptosis may be important for improving the ef®cacy of PDT
for the treatment of skin cancer and possibly other cancers and/or
similar pathologic conditions. It is also conceivable that a synergistic
activation of Fas-FasL pathways via a combination therapy may
enhance the therapeutic ef®cacy of PDT.
This study was supported by USPHS grants RO1 CA 51802, PO1 CA 48735,
P30 CA 43703, and P30 AR 39750. N.A. was a recipient of a Career
Development Award from Dermatology Foundation, U.S.A.
REFERENCES
Agarwal ML, Larkin HE, Zaidi SIA, Mukhtar H, Oleinick NL: Phospholipase
activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer
Res 53:5897±5902, 1993
Agarwal R, Korman NJ, Mohan RR, Feyes DK, Jawed S, Zaim MT, Mukhtar H:
Apoptosis is an early event during phthalocyanine photodynamic therapy-
induced ablation of chemically induced squamous papillomas in mouse skin.
Photochem Photobiol 63:547±552, 1996
Ahmad N, Feyes DK, Agarwal R, Mukhtar H: Photodynamic therapy results in
induction of WAF1/CIP1/p21 leading to cell cycle arrest and apoptosis. Proc
Natl Acad Sci USA 95:6977±6982, 1998
Ahmad N, Gupta S, Mukhtar H: Involvement of retinoblastoma (Rb) and E2F
transcription factors during photodynamic therapy of human epidermoid
carcinoma cells A431. Oncogene 18:1891±1896, 1999
Assefa Z, Vantieghem A, Declercq W, et al: The activation of the c-Jun N-terminal
kinase and p38 mitogen-activated protein kinase signaling pathways protects
HeLa cells from apoptosis following photodynamic therapy with hypericin. J
Biol Chem 274:8788±8796, 1999
Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F, Gulbins E: Fas-
or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of
Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 272:22173±
22181, 1997
Brenner B, Ferlinz K, Grassme H, et al: Fas/CD95/Apo-1 activates the acidic
sphingomyelinase via caspases. Cell Death Differ 5:29±37, 1998
Catlett IM, Bishop GA: Cutting edge: a novel mechanism for rescue of B cells from
CD95/Fas-mediated apoptosis. J Immunol 163:2378±2381, 1999
Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-
containing protein, interacts with the death domain of Fas and initiates
apoptosis. Cell 81:505±512, 1995
Colussi VC, Feyes DK, Mukhtar H: Perspectives of photodynamic therapy for skin
diseases. Skin Pharmacol Appl Skin Physiol 11:336±346, 1998
Colussi VC, Feyes DK, Mulvihill JW, et al: Phthalocyanine 4 (Pc 4) photodynamic
therapy of human OVCAR-3 tumor xenografts. Photochem Photobiol 69:236±
241, 1999
Dougherty TJ, Gomer CJ, Henderson BW, et al: Photodynamic therapy. J Natl
Cancer Inst 90:88±91, 1998
Fraser A, Evan G: A license to kill. Cell 85:781±784, 1996
Fritsch C, Goerz G, Ruzicka T: Photodynamic therapy in dermatology. Arch
Dermatol 134:207±214, 1998
Gomer CJ, Ryter SW, Ferrario A, Rucker N, Wong S, Fisher AM: Photodynamic
therapy-mediated oxidative stress can induce expression of heat shock proteins.
Cancer Res 56:2355±2360, 1996
Granville DJ, Carthy CM, Jiang H, Shore GC, McManus BM, Hunt DW: Rapid
cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31
cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett 437:5±
10, 1998
Granville DJ, Jiang H, An MT, Levy JG, McManus BM, Hunt DW: Overexpression
of Bcl-X (L) prevents caspase-3-mediated activation of DNA fragmentation
factor (DFF) produced by treatment with the photochemotherapeutic agent
BPD-MA. FEBS Lett 422:151±154, 1998
Gupta S, Ahmad N, Mukhtar H: Involvement of nitric oxide during phthalocyanine
(Pc4) photodynamic therapy-mediated apoptosis. Cancer Res 58:1785±1788,
1998
He J, Agarwal ML, Larkin HE, Friedman LR, Xue LY, Oleinick NL: The induction
of partial resistance to photodynamic therapy by the protooncogene BCL-2.
Photochem Photobiol 64:845±852, 1996
Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub
LB: Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science
285:898±900, 1999
Juo P, Kuo CJ, Yuan J, Blenis J: Essential requirement for caspase-8/FLICE in the
initiation of the Fas-induced apoptotic cascade. Curr Biol 8:1001±1008, 1998
Kalka K, Merk HF, Mukhtar H: Photodynamic therapy in dermatology (CME
article). J Am Acad Dermatol 42:389±413, 2000
Kim HR, Luo Y, Li G, Kessel D: Enhanced apoptotic response to photodynamic
therapy after bcl-2 transfection. Cancer Res 59:3429±3432, 1999
Klotz LO, Fritsch C, Briviba K, Tsacmacidis N, Schliess F, Sies H: Activation of JNK
and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-
photodynamic therapy. Cancer Res 58:4297±4300, 1998
Luna MC, Wong S, Gomer CJ: Photodynamic therapy mediated induction of early
response genes. Cancer Res 54:1374±1380, 1994
Muzio M, Chinnaiyan AM, Kischkel FC, et al: FLICE, a novel FADD-homologous
ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-
inducing signaling complex. Cell 85:817±827, 1996
Oleinick NL, Evans HH: The photobiology of photodynamic therapy: cellular
targets and mechanisms. Radiation Res 150 (Suppl.):S146±S156, 1998
Oleinick NL, Antunez AR, Clay ME, Rihter BD, Kenney ME: New phthalocyanine
photosensitizers for photodynamic therapy. Photochem Photobiol 57:242±247,
1993
Peter ME, Krammer PH: Mechanisms of CD95 (APO-1/Fas) -mediated apoptosis.
Curr Opin Immunol 10:545±551, 1998
Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM: Ultraviolet radiation-
induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol
Chem 272:25783±25786, 1997
Ryter SW, Gomer CJ: Nuclear factor kappa B binding activity in mouse L1210 cells
following photofrin II-mediated photosensitization. Photochem Photobiol
58:753±756, 1993
Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME: Apoptosis signaling
by death receptors. Eur J Biochem 254:439±459, 1998
Separovic D, He J, Oleinick NL: Ceramide generation in response to photodynamic
treatment of L5178Y mouse lymphoma cells. Cancer Res 57:1717±1721, 1997
Separovic D, Mann KJ, Oleinick NL: Association of ceramide accumulation with
photodynamic treatment-induced cell death. Photochem Photobiol 68:101±109,
1998
Tajiri H, Hayakawa A, Matsumoto Y, Yokoyama I, Yoshida S: Changes in
intracellular Ca2+ concentrations related to PDT-induced apoptosis in
photosensitized human cancer cells. Cancer Lett 128:205±210, 1998
Tao J, Sanghera JS, Pelech SL, Wong G, Levy JG: Stimulation of stress-activated
protein kinase and p38 HOG1 kinase in murine keratinocytes following
photodynamic therapy with benzoporphyrin derivative. J Biol Chem
271:27107±27115, 1996
Varnes ME, Chiu SM, Xue LY, Oleinick NL: Photodynamic therapy-induced
apoptosis in lymphoma cells: translocation of cytochrome c causes inhibition of
respiration as well as caspase activation. Biochem Biophys Res Commun 255:673±
679, 1999
Zaidi SI, Oleinick NL, Zaim MT, Mukhtar H: Apoptosis during photodynamic
therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic,
histopathologic and biochemical evidence. Photochem Photobiol 58:771±776,
1993
Zhuang S, Lynch MC, Kochevar IE: Caspase-8 mediates caspase-3 activation and
cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells.
Exp Cell Res 250:203±212, 1999
1046 AHMAD ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
